Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | CD19 car circRNA-LNP, CD19-targeting circular RNA chimeric antigen receptor lipid nanoparticles |
| Catalog Number | R-CD19 car circRNA-LNP |
| Appearance | Milky white or translucent nanoparticle suspension |
| Molecular Formula | N/A |
| Solubility | / |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | gene therapy research |
| Specification | 100mg:Inquiry 200mg:Inquiry 500mg:Inquiry |
| Description | CD19 car circRNA-LNP is a revolutionary gene-immune treatment complex system that innovatively combines three cutting-edge technologies: chimeric antigen receptor (CAR) targeting CD19, circular RNA (circRNA) gene expression platform and lipid nanoparticle (LNP) delivery system. This product aims to overcome the key limitations of traditional disease-poison vector CAR-T therapies, such as long preparation cycles, high costs, potential risks of insertional mutations and complex in vitro manufacturing processes, and provide a safer, faster and scalable treatment option for B cell malignant tumors. |